ECOP4 Advance Programme (Last Update: 22/10/2018)

Thursday, 25 October 2018

Workshop: MASHA Training (closed session – invitation only)

08:30 – 10:30
Room KL

Coordinator: E. Korczowska (Poland)

Coordinator: K. Meier (Germany)
Coordinator: B. Tans (Belgium)

Workshop: Pharmacovigilance: How to Classify Severity and How to Establish Causality

09:30 - 10:30 Room 200

Coordinator: M. Sonc (Slovenia)

Workshop: Love and Sexuality of Oncological Patients

09:30 - 10:30 Room GH

Coordinator: V. Pavlica (Croatia)

Sexual problems in people with lung cancer and breast cancer and how
to treat them
Speaker: G. Arbanas (Croatia)
Quality of life for patients treated with rectal cancer
Speaker: O. Spasovska (Macedonia)
Effects of oncologic disease and treatment on patients sexuality
Speaker: J. Vrbanec (Croatia)

1
Clinical Symposium: Immunotherapy

14:00 - 16:00 Auditorium

Chair: A. Astier (France)

14:00 Future directions for immunotherapy: The quest for biomarkers
Speaker: W. Weichert (Germany)
14:30 Current concepts in the management of immunotherapy related side-effects
Speaker: M. Boers-Sonderen (Netherlands)
15:00 Immunotherapy in cancer; safety management in an ambulatory approach
Speaker: E. Moreno Martinez (Spain)
15:30 Questions & Answers

Debate - Clinical / Practical: Safe Compounding

14:00 – 15:00 Room 200

Moderator: K. Meier (Germany)

14:00 This house believes that occupational exposure can be effectively reduced using
spikes with good handling procedures
Speaker: O. Breukels (Netherlands)
14:20 This house believes that occupational exposure can only be reduced further by using
closed-system devices
Speaker: Y. Cass (Israel)
14:40 Conclusion and final statements
Speaker: E. Korczowska (Poland)

New Horizons - Clinical: Liquid Biopsies and Volatile Markers in Cancer

15:00 - 16:00 Room 200

Chair: V. Pavlica (Croatia)

15:00 Clinical significance of circulating DNA in breast cancer
Speaker: H. Schwarzenbach (Germany)
15:25 Diagnosis of leukemia in children via breath analysis
Speaker: L Konieczna (Poland)
15:50 Questions & Answers

2
ECOP4 Opening Ceremony

16:15 - 16:45 Auditorium

16:15 Welcome to Nantes from representative of the Mayor & Municipality of Nantes
B. Asseh
16:25 Welcome from EU Commissioner (video address)
V. Andriukaitis

16:30 Welcome by ESOP President

K. Meier
Welcome by ECOP4 Scientific Chair
M. Crul
A musical taste of Nantes!
16:40 Welcome by the Local Organising Committee
C. Bardin

Keynote Session

16:45 - 18:00 Auditorium

Chair: K. Meier (Germany)

16:45 Presentation by MEP Alojz Peterle
Speaker: A. Peterle (Slovenia)
17:15 Patient participation in clinical trials and medicines development strategies
Speaker: I. Klingmann (Belgium)

18:00 Questions & Answers

Exhibitor's Reception / Poster Viewing

18:00 - 19:30 Exhibition Area Mezzanine

3
Friday, 26 October 2018

Workshop: Patient Counselling in Oncology - The Role of the Pharmacist

08:30 - 09:30 Auditorium

Coordinator: V. Pavlica (Croatia)

Workshop: Value Based Pharmacy: Developing Qualitative Parameters for Drugs and Public
Procurement

08:30 - 09:30 Room 200

Coordinator: M. Skelin (Croatia)

Coordinator: E. Javor (Croatia)

Workshop: The Role of the Oncology Pharmacist in Clinical Trials

08:30 - 09:30 Room GH

Coordinator: C. Bardin (France)

Coordinator: E. Korczowska (Poland)

Keynote Lecture: New Therapies

09:30 - 10:30 Auditorium

Chair: A. Bosnak (Turkey)

09:30 New Drugs in Oncology
Speaker: M. Muenzberg (Switzerland)
10:15 Question & Answers

Clinical Symposium: Geriatric Oncology - Joint ESOP - SIOG Symposium

11:00 - 12:00 Auditorium

Chair: C. Groos (Luxembourg)

11:00 Systemic cancer treatment in the elderly: Frailty assessment tools and who is fit for
chemo?
Speaker: S. O'Hanlon (Ireland)
11:25 Balancing between best treatment outcome and preserving quality of life
Speaker: L. Mourey (France)
11:50 Question & Answers

4
Practical Symposium: ESO - ESOP Joint Symposium

11:00 - 12:00 Room 200

Chair: K. Tsiakitzis (Greece)

11:00 A new perspective, Clinical Oncology Pharmacy Service connected to the Pharmacy
Faculties
Speaker: A.S. Bosnak (Turkey)
11:25 Multiprofessional education in oncology
Speaker: M. Aapro (Switzerland)
11:50 Questions & Answers

Symposium: Cost Management of Cancer Care

11:00 - 12:00 Room GH

Chair: K. Kongi (Estonia)

11:00 Repositioning some old drugs as anticancer agents
Speaker: A. Astier (France)
11:25 The role of the French National Cancer Institute
Speaker: M. Dahan (France)
11:50 Questions & Answers

Clinical Symposium: Prevention and Management of Side Effects

12:00 - 13:00 Auditorium

Chair: A. Eberl (Slovenia)

12:00 Prevention and management of chemotherapy side-effects: are we doing enough?
Speaker: P. Dürr (Germany)
12:25 Adverse drug reactions to oral chemotherapy and patient education
Speaker: N. Vilaca Marques (Portugal)
12:50 Questions & Answers

New Horizons - Practical: Automation and Robotics in Oncology Pharmacy

12:00 - 13:00 Room 200

Chair: T.A. Schöning (Germany)

12:00 Full automation of aseptic preparation of antineoplastics drugs: robotic
experience
Speaker: E.B. Lunde (Norway)
12:25 Automated dispensing systems and oral chemotherapy
Speaker: J. Wennek-Klosse (Germany)
12:50 Questions & Answers

5
Round Table Discussion: Pharmacoeconomic Evaluation of Oncology Drugs

12:00 - 13:00 Room GH

Moderator: M. Daouphars (France)

12:00 Moving from traditional chemotherapy towards molecularly targeted therapies -
Pharmacoeconomic impact of orphan drugs
Speaker: K. Tsiakitzis (Greece)
12:20 Biosimilar perspective
Speaker: A. Astier (France)
12:40 The role of decision making in pharmacoeconomics for oncological drugs
Speaker: E. Pizzo (United Kingdom)

Posters in the Spotlight:

15:30 - 16:30 Poster Area R2

Chair/ Moderator: C. Bardin (France)

What is the best safety way in computerized system for hospital prescribers and
pharmacists to switch to biosimilars? Evaluation with pertinent criteria helping
L. Sartfati (France)
Development of an analytical method to assess the occupational health risk of
therapeutic monoclonal antibodies using liquid chromatography and high-
resolution mass spectrometry
M. Klassen (Germany)
Improving the safety of pediatric cytotoxic drugs preparations: how to meet the
challenge?
K. Morand (France)

Clinical Interactive Session: Supportive Care

16:30 - 18:00 Auditorium

Chair: K. Kongi (Estonia)

16:30 Psychotropic drugs in oncological supportive care: Clinical experience
Speaker: I. Netikova (Czech Republic)
16:50 Cardiotoxicity of oncology drugs and measures to preserve cardiac function
Speaker: M. Aapro (Switzerland)
17:10 Proffered Paper: CAR-T Cells : consequences for the hospital pharmacists
F. Cartier (France)
17:25 Proffered Paper: Effectiveness and safety of perioperative treatment with
epirubycin, oxaliplatin and capecitabin in patients with advanced
gastroesophageal cancer
A. Munilla-Das (Spain)
17:40 Proffered Paper: Development of an online drug-drug interaction resource to
support safe prescription of oncolytics
N. Van Erp (Netherlands)
17:55 Question & Answers

6
Practical Interactive Session: Drug Stability

16:30 - 18:00 Room 200

Chair: L. Horvath (Hungary)

16:30 Stability after reconstitution and dilution: Filling the GAP in the SmPC
Speaker: J. Vigneron (France)
16:50 Stability studies: how to perform, how to read, how to use
Speaker: E. d’Huart (France)
17:10 Proffered Paper: Screening methods for leachables in syringes used in Hospital
Pharmacy Production
R. Trittler (Germany)
17:25 Proffered Paper: Prevalence and potential severity of antineoplastic drugs
preparation errors detected during quality control of the process
M.B. Marzal Alfaro (Spain)
17:40 Proffered Paper: Pemetrexed stability: additional information about
microparticles
E. D’Huarte (France)
17:55 Questions & Answers

Practical Symposium: Joint SIOPE - ESOP Symposium: Dose Banding

16:30 - 18:00 Room GH

Chair: S. Hosny Kamal (Egypt)
16:30 Utilising pharmacokinetic data to investigate the potential impact of dose
banding for systemic therapy in a childhood cancer setting
Speaker: J.G. Veal (United Kingdom)
17:00 Dose banding in Pediatric Oncology
Speaker: S. Hosny Kamal (Egypt)
17:30 Discussion

7
Saturday, 27 October 2018

Keynote Session

08:30 - 10:00 Auditorium

Chair: C. Bardin (France)

08:30 Counterfeiting medicine: Start with the facts
Speaker: B.J. Venhuis (Netherlands)
09:10 Eventually true results: How statistics in clinical trials work
Speaker: P.F. Conte (Italy)
09:50 Questions & Answers

Symposium: ECCO-ESOP Joint Symposium: ERQCC

10:00 - 11:30 Auditorium

Chair: M. Crul (Netherlands)

10:00 Oncology pharmacist as a part of multi-professional team involved in the
treatment of oncology patient
Speaker: M. Skelin (Croatia)
10:30 Essential requirements in colorectal cancer care
Speaker: P. Naredi (Sweden)
11:00 Questions & Answers

Practical Symposium: Practical Oncology Pharmacy

10:00 - 11:30 Room 200

Chair: A. Munilla (Spain)

10:00 Flat dosing versus weight based dosing of monoclonal antibodies
Speaker: J. Hendrix (Netherlands)
10:25 Cytostatics decontamination based on nanoparticles agent
Speaker: I. Netikova (Czech Republic)
10:50 Proffered Paper: Evaluation of an intelligent video camera system in a
pharmacy service : feedback on 2 years of experiences
M. Laplace (France)
11:05 Proffered Paper: The antimicrobial activity of anticancer drugs: In vitro study
of the most used anticancer molecules in chemotherapy
I. Bennani (Morocco)
11:20 Questions & Answers

8
Posters in the Spotlight:

11:30 - 12:30 Poster Area R2

Chair/ Moderator: M. Daouphars (France)
Vorinostat represses neural markers in glioblastoma cells and induces
transdifferenciation toward mural lineage
T. Perez (France)
Potential drug cost savings associated with lymphoma clinical trials
C. Herledan (France)
Evaluation of clinical pharmacist’s contribution in a French cancer center:
clinical impact and cost-saving
M. Michard (France)
Relationship between mutations in the HSD3B1 gene and response time to
androgen deprivation therapy in the treatment of prostate cancer
S. Garcia Gil (Spain)

Clinical Interactive Session: Clinical Oncology Pharmacy Session

12:30 - 13:30 Auditorium

Chair: I. Netikova (Czech Republik)
12:30 Pharmacological challenges and different dose optimization potentials of the
two very distinct groups of targeted drugs: Nibs vs Mabs
Speaker: N. van Erp (Netherlands)
12:50 Arsenical derivatives as anticancer agents
Speaker: S. Gibaud (France)
13:10 Proffered Paper: Impact of pharmaceutical interventions on costs in an
ambulatory haematology-oncology unit
M. Boulin (France)
13:25 Proffered Paper: CONEcT: Promoting therapeutic education in oral
chemotherapy. From training to implementation of a program between primary
and secondary care
M. Cordier (France)

Special Session: Patient Perspectives

12:30 - 13:30 Room 200

Chair: M. Crul (Netherlands)
12:30 At work and home with and after cancer
Speaker: I. Banks (United Kingdom)
12:55 Patient reported outcomes and patient reported adverse events
Speaker: N. York (United Kingdom)
13:20 Questions & Answers

Closing Remarks, Conference Highlights, Announcing ECOP 5 in 2020, Awards

13:45 - 14:00 Auditorium
Chair: K. Meier (Germany)
- Yellow Hand Award